The genetics of bleeding disorders: A report on the UK Haemophilia Centre Doctors' Organization annual scientific symposium, 10th October 2003

Haemophilia

Volumn 10, Issue 4, 2004, Pages 390-396

  Nicolle, A I ^a   Talks, K L ^a   Hanley, John ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Gene therapy; Genetic counselling; Genetics; Haemophilia; Prenatal diagnosis

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DNA; FATTY ACID BINDING PROTEIN; PARVOVIRUS VECTOR; PROTEIN C; PROTHROMBIN;

ADENO ASSOCIATED VIRUS; BLEEDING DISORDER; CLINICAL GENETICS; CLINICAL TRIAL; CONFERENCE PAPER; GENETIC ANALYSIS; GENETIC COUNSELING; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEMOPHILIA; HUMAN; HUMAN GENETICS; LIVER TOXICITY; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL GENETICS; MEDICAL SOCIETY; MEDICAL SPECIALIST; MOLECULAR GENETICS; NURSE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SYMPOSIUM; THROMBOCYTOPENIA; UNITED KINGDOM; VIRAL GENE THERAPY; VON WILLEBRAND DISEASE;

EID: 4043172729     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2004.00929.x     Document Type: Conference Paper

References (19)

1. Department of Health. Our Inheritance, Our Future: Realising the Potential of Genetics in the NHS. Department of Health, London, England, 2003.
2. Mazza V, Falcinelli C, Percesepe A, Paganelli S, Volpe A, Forabosco A. Non invasive first trimester fetal gender assignment in pregnancies at risk for X-linked recessive diseases. Prenat Diagn 2002; 22: 919-24.
3. Lo YM, Hjelm NM, Fidler C et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998; 339: 1734-8.
4. Chiu RW, Murphy MF, Fidler C, Wainscoat JS, Lo YM. Technical optimization of RhD zygosity determination by real-time quantitative polymerase chain reaction: implication for fetal RhD status determination by maternal plasma. Ann NY Acad Sci 2001; 945: 156-60.
5. Costa JM, Benachi A, Gautier E, Jouannic JM, Ernault P, Dumez Y. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn 2001; 21: 1070-4.
6. Ljung RC. Prenatal diagnosis of haemophilia. Haemophilia 1999; 5: 84-7.
7. Tedgard U, Ljung R, McNeil TF. Reproductive choices of haemophilia carriers. Br J Haematol 1999; 106: 421-6.
8. Tedgard U, Ljung R, McNeil TF. Long term psychological effects of carrier testing and prenatal diagnosis of haemophilia: comparison with a control group. Prenat Diagn 1999; 19: 411-7.
9. The RCN Haemophilia Nurses Association. A Competency Framework for Nurses Caring for People with Haemophilia and Other Related Bleeding Disorders. The Royal College of Nursing, London, England, 2002.
10. Keeney S, Cumming AM. The molecular biology of von Willebrand disease. Clin Lab Haem 2001; 23: 209-30.
11. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-93.
12. Castaman G, Eikenboom JC, Bertina RM, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 1065-70.
13. Casana P, Martinez F, Haya S, Espinos C, Aznar JA. Significant linkage and non-linkage of type1 von Willebrand disease to the von Willebrand factor gene. Br J Haematol 2001; 115: 692-700.
14. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
15. O'Brien LA, James PD, Othman M et al. The Association of Haemophilia Clinic Directors of Canada. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 2003; 102: 549-57.
16. Kay MA, Manno CS, Ragni MV et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257-61.
17. Manno CS, Chew AJ, Hutchison S et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003; 101: 2963-72.
18. Roth DA, Tawa NE Jr, O'Brien JM, Treco DA, Selden RF for the Factor VIII Transkaryotic Therapy Study Group. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N Engl J Med 2001; 23: 1735-42.
19. Powell JS, Ragni MV, White GC II et al. Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion. Blood 2003; 102: 2038-45.